The Biomarker: Melanoma
Sanjiv S. Agarwala, MD
Video Categories: The Biomarker
PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
December 12, 2016
Sunil Verma, MD, MSEd, FRCPC takes up the topic of communicating with patients about what they want for their care.
September 20, 2013
Grant Lawless discusses the long term goal of personalized medicine as it relates to the Affordable Care Act